Previous Close | 7.70 |
Open | 8.10 |
Bid | 4.40 |
Ask | 8.70 |
Strike | 45.00 |
Expire Date | 2025-01-17 |
Day's Range | 7.70 - 8.10 |
Contract Range | N/A |
Volume | |
Open Interest | 18 |
On June 3, 2024, Julie Hambleton, Director at SpringWorks Therapeutics Inc (NASDAQ:SWTX), sold 4,648 shares of the company.
Badreddin Edris, the Chief Operating Officer of SpringWorks Therapeutics Inc (NASDAQ:SWTX), sold 20,000 shares of the company on June 3, 2024, according to a recent SEC filing.
On June 3, 2024, Saqib Islam, the Chief Executive Officer of SpringWorks Therapeutics Inc (NASDAQ:SWTX), executed a sale of 49,000 shares of the company.